Capsugel expands capsule line with Encap purchase; TheraCoat introduces hydrogel delivery for bladder diseases;

@MichaelGFierce: Yale researchers improve lupus drug with nanogel delivery. More | Follow @MichaelGFierce

> Capsugel bought Scottish company Encap Drug Delivery in an effort to bolster its formulation and manufacturing business, adding liquid and semi-solid capsules on top of its line of hard-capsule drugs. Article

> TheraCoat developed a hydrogel-based drug delivery system that enables more controlled treatment of bladder diseases and is seeking commercial partners. Release

> Last month, President Barack Obama awarded MIT professor and drug delivery innovator Robert Langer with the National Medal of Technology and Innovation--in-Pharma Technologist caught up with Langer for an interview.

> The FDA is scheduled to review Titan Pharmaceuticals' Probuphine, a subdermal implant for the treatment of opioid dependence, near the end of March. Release

> Researchers at the University of Cincinnati have developed circulating microbubbles that encapsulate and shield drugs in the blood stream during the treatment of cardiovascular diseases. Abstract

> Ranbaxy Pharmaceuticals entered an agreement with Alembic Pharmaceuticals to exclusively market Alembic's extended release depression drug desvenlafaxine in the U.S. Item

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.